A Phase 1b/2, With Phase 2 Randomized, Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRα Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced Soft Tissue Sarcoma
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007290/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to gather information about the use of an investigational
drug called olaratumab with a drug for soft tissue sarcoma called doxorubicin.
提供机构：
Vivli
创建时间：
2021-07-16
